Literature DB >> 16394901

Abdominal insufflation decreases blood loss and mortality after porcine liver injury.

Amín Jaskille1, Adam Schechner, Ken Park, Michael Williams, Dennis Wang, Jack Sava.   

Abstract

BACKGROUND: Uncontrolled intra-abdominal bleeding is a common cause of death in trauma patients in the prehospital and perioperative settings. The detrimental effects of abdominal hypertension are well studied, but the potential therapeutic use of abdominal insufflation for hemostasis has not been fully explored. We measured the effect of abdominal insufflation on blood loss and physiologic outcomes in a swine model of blunt liver injury.
METHODS: Twenty-one anticoagulated swine (32 +/- 3 kg) were anesthesized; laparotomy was performed to localize liver anatomy and to place loose tourniquettes isolating the porta hepatis and supra/infrahepatic vena cava. A captive bolt gun was used to create a grade V hepatic laceration, producing massive parenchymal injury as well as complex tears of the middle and right hepatic veins. Animals were randomized into either control (n = 10) or abdominal insufflation at 20 cm H(2)O pressure (n = 11) groups. Crystalloid was used to maintain a mean arterial pressure of 30 mm Hg. Arterial pressure and other physiologic variables were recorded for 20 minutes. Animals were then sacrificed and blood loss measured.
RESULTS: Blood loss was 69% lower in insufflated animals compared with controls (384 +/- 51 versus 1252 +/- 88 cc, p < 0.001). After 20 minutes, insufflated animals had significantly higher mean arterial blood pressure (32.2 +/- 4.2 versus 21.2 +/- 4.0 mm Hg) and lower total resuscitation volume (195 +/- 83 versus 1356 +/- 95 cc). Three pigs died in the control group (30%), whereas no insufflated animals died (p < 0.05).
CONCLUSION: In a swine model of catastrophic blunt hepatic injury, abdominal insufflation significantly decreased blood loss and mortality.

Entities:  

Mesh:

Year:  2005        PMID: 16394901     DOI: 10.1097/01.ta.0000198374.16218.ca

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Meng Xiangfei; Xu Yinzhe; Pan Yingwei; Lu Shichun; Duan Weidong
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

Review 2.  Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations.

Authors:  Martin Gaillard; Hadrien Tranchart; Ibrahim Dagher
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

3.  The association between central venous pressure, pneumoperitoneum, and venous carbon dioxide embolism in laparoscopic hepatectomy.

Authors:  S Jayaraman; A Khakhar; H Yang; D Bainbridge; D Quan
Journal:  Surg Endosc       Date:  2009-03-06       Impact factor: 4.584

Review 4.  Intravenous hemostats: challenges in translation to patients.

Authors:  Margaret Lashof-Sullivan; Andrew Shoffstall; Erin Lavik
Journal:  Nanoscale       Date:  2013-10-02       Impact factor: 7.790

5.  Blood oxygenation during hyperpressure intraperitoneal fluid administration in a rabbit model of severe liver injury: Evaluation of a novel concept for control of pre-hospital liver bleeding.

Authors:  Siavash Ahmadi-Noorbakhsh; Saeed Azizi; Bahram Dalir-Naghadeh; Masoud Maham
Journal:  Vet Res Forum       Date:  2012       Impact factor: 1.054

Review 6.  Current status of laparoscopic liver resection for hepatocellular carcinoma.

Authors:  Hanisah Guro; Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; YoungRok Choi; Mohan Periyasamy
Journal:  Clin Mol Hepatol       Date:  2016-06-15

Review 7.  Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting.

Authors:  S E van Oostendorp; E C T H Tan; L M G Geeraedts
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-13       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.